AtaiBeckley (ATAI) Times Interest Earned (2022 - 2025)
AtaiBeckley (ATAI) posted quarterly Times Interest Earned of -$0.52 for Q1 2026, up 97.69% year-over-year from -$0.26 in Q1 2025, and up 97.69% quarter-over-quarter from -$22.63 in Q1 2025.
Powered by 
Analysis
AtaiBeckley (ATAI) Times Interest Earned (2022 - 2025) Analysis & Trends
AtaiBeckley has reported Times Interest Earned for 6 years, with the latest figure at -$0.24 in Q3 2025.
- Quarterly Times Interest Earned rose 96.43% year-over-year to -$0.24 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$0.88 (up 97.21% YoY) and the FY2024 annual result came in at -$0.74, up 47.22% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.52, up from -$22.63 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.52 in Q1 2026, with the low at -$22.63 in Q1 2025.
- A 5-year average of $3.95 and a median of -$3.12 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned sank 12532.24% in 2021, then jumped 2063.38% in 2023.
- Over 5 years, Times Interest Earned stood at -$0.15 in 2021, then sank by 26217.41% to -$40.7 in 2022, then jumped by 2063.38% to $799.07 in 2023, then tumbled by 97.73% to $18.1 in 2024, then tumbled by 101.32% to -$0.24 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.24, -$1.3, and -$22.63 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -95.73 |
| Jun 30, 2025 | -95.73 |
| Mar 31, 2025 | -22.63 |
| Mar 31, 2025 | -22.63 |
| Dec 31, 2024 | -31.79 |
| Sep 30, 2024 | -28.87 |
| Jun 30, 2024 | -36.65 |
| Mar 31, 2024 | -35.06 |
| Dec 31, 2023 | -48.57 |
| Sep 30, 2023 | -39.12 |
| Jun 30, 2023 | -48.42 |
| Mar 31, 2023 | -53.40 |
| Dec 31, 2022 | -40.70 |